Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Brain Tumours Equipment Supplied In Usa
51 equipment items found
Manufactured by:Mevion Medical Systems based inLittleton, MASSACHUSETTS (USA)
The MEVION S250i™ with HYPERSCAN™ pencil beam scanning technology delivers high-quality, robust Intensity Modulated Proton Therapy (IMPT) treatments at hyper-speed and without ...
Manufactured by:Lumos Pharma based inAustin, TEXAS (USA)
Growth hormone (GH) deficiency is the consequence of inadequate secretion of growth hormone from the pituitary gland. This results in low GH in the body, insufficient production of downstream signaling molecules required for growth, and the subsequent lack of growth. In children, this rare disorder is called pediatric growth hormone deficiency (PGHD). Secretion of GH is under strict hormonal ...
Manufactured by:Stanford Chemicals Company based inLake Forest, CALIFORNIA (USA)
Remdesivir (development code GS-5734) is a novel antiviral drug in the class of nucleotide analogs. It is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of 2019-nCoV (COVID-19) infection in ...
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
SL-701 is an immunotherapy designed to direct the immune system to attack targets present on certain malignancies including brain cancer. SL-701 comprises 3 short synthetic peptides that correspond to epitopes of targets including IL-13Rα2, EphA2, and survivin; 2 of these synthetic peptides (IL-13Rα2 and survivin) are mutant and believed to enhance immune activity. A multicenter Phase ...
Manufactured by:Monteris Medical based inMinnetonka, MINNESOTA (USA)
The Robotic Probe Driver, designed for use with a skull anchor like the Monteris Mini-Bolt, reduces profile in the MRI for access to virtually any brain location along the ideal ...
by:TAE Life Sciences (TLS) based inFoothill Ranch, CALIFORNIA (USA)
TAE Life Sciences is committed to developing a portfolio of novel targeted boron drugs to expand the application of BNCT to other cancer types and to provide even better outcomes for indications historically treated with Boronophenylalanine (BPA), a boron delivery ...
Manufactured by:Reglagene Holding, Inc. based inTucson, ARIZONA (USA)
Only 4 of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009, but this medicine did not extend life expectancy. Patients deserve better therapies that extend life and improve quality of life. The Reglagene team is developing a first-in-class blood–brain barrier (BBB) penetrant medicine that effectively fights brain ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
Human (Parental) Brain Cancer Stem Cell (Plated cells are also available). 120 Population doublings or up to 12 passages. One million viable cells upon thawing of frozen cells, frozen vial of cells shipped in dry-ice. Cell Cultures from single donors, 1000 different cell cultures available, please indicate which lots you require from the 1000 donors. Source: Human Parental Brain Cancer Tissue ...
Manufactured by:Theriva Biologics, Inc., formely known as ynthetic Biologics, Inc. based inRockville, MARYLAND (USA)
Building on the clinical advancement of VCN-01, Theriva developed the Albumin Shield™ technology to protect oncolytic viruses from circulating anti-oncolytic virus antibodies after systemic administration. We anticipate that this technology will enable multiple oncolytic virus doses to be administered in therapeutic cycles to treat particularly refractory ...
Manufactured by:Centerline Biomedical based inCleveland, OHIO (USA)
Centerline Biomedical’s Intra-Operative Positioning System (IOPS) technology is an innovative, 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure. ...
Manufactured by:Avery Biomedical Devices, Inc. based inCommack, NEW YORK (USA)
Central Sleep Apnea is a sleep disorder characterized by pauses in breathing during sleep, though it can also affect a patient’s respiratory effort while awake, and is a result of the brain failing to send the proper signals to the muscles that are in control of breathing. Central Sleep Apnea can be a congenital or acquired condition, with the acquired condition typically being the result ...
Manufactured by:Novodiax, Inc. based inHayward, CALIFORNIA (USA)
Cluster of Differentiation 20 (CD20) is a polymerized horseradish peroxidase (pHRP)-labeled anti-CD20 (R272) rabbit monoclonal antibody intended for laboratory use using frozen or formalin-fixed-paraffin-embedded tissues. CD20 also known as B-lymphocyte antigen, is a membrane polypeptide protein that is present in a majority of B-cells in peripheral blood and lymphoid ...
Manufactured by:ZAP Surgical Systems, Inc. based inSan Carlos, CALIFORNIA (USA)
Leveraging unique gyroscopic motion, the ZAP-X platform opens new frontiers in modern radiosurgery. Combining self-shielding technology with high dose rate linear-accelerator delivery, ZAP-X was created to safely treat more patients in more ...
Manufactured by:TVAX Biomedical, Inc. based inOlathe, KANSAS (USA)
TVAX®’s lead candidate (TVI-Brain-1) is being evaluated for the treatment of brain cancer and targets glioblastomas. The drug candidate has received Fast Track Designation by the US Food and Drug Administration (FDA) to test TVI-Brain-1 in a Phase 2b clinical study for glioblastoma multiforme (GBM). The Fast Track Designation is supported by positive Phase 2 clinical data, as well as ...
Manufactured by:Monteris Medical based inMinnetonka, MINNESOTA (USA)
Dependable skull fixation for neurosurgical devices. The only cranial fixation bolt with a robotic interface to enable precise laser delivery. ...
Manufactured by:Novodiax, Inc. based inHayward, CALIFORNIA (USA)
Cluster of Differentiation 45 (CD45) pHRP Anti-Human Staining Kit immunohistochemistry (IHC) reagent is for use on frozen and formalin-fixed-paraffin-embedded tissues. The CD45 antigen is a protein which was originally called Leukocyte Common Antigen and recognizes an antigen found on lymphoid cells. Anti-CD45 antibody is a useful tool for identifying tumor cells of lymphoid ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The versatile Xoft Axxent® Electronic Brachytherapy (eBx) System utilizes breakthrough electronic brachytherapy technology to provide expanded treatment options for a range of cancers. With the Axxent controller, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy ...
Manufactured by:Invenio Imaging Inc. based in2310 Walsh Ave, CALIFORNIA (USA)
The NIO Laser Imaging System uses Stimulated Raman Histology to image unprocessed tissue specimen without sectioning or staining, enabling histologic evaluation outside the laboratory. It has been used in over 2000 brain tumor procedures across multiple institutions in the United States and in Europe. ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
Our proprietary, miniaturized x-ray source is isotope-free and operates at 50 kV to deliver high dose rate, low energy radiation. The source is placed inside the applicator and energized to deliver a precise, prescribed dose of radiation. With the Xoft System, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
Worldwide, almost 297,000 cases of brain and nervous system tumors are diagnosed per year. Glioblastoma (GBM) is the most common and aggressive type of malignant primary brain tumor, with a median survival of 10-12 months. Treatment for brain tumors typically involves surgical removal, followed by radiation therapy or chemotherapy. Xoft brain IORT is a promising treatment option that may offer ...